Literature DB >> 24669352

Sublingual Immunotherapy for Asthma: Affects T-Cells but Does not Impact Basophil Activation.

Olga Ciepiela1, Anna Zawadzka-Krajewska2, Iwona Kotuła1, Frans van Overveld3, Marek Kulus2, Urszula Demkow1.   

Abstract

Objective: Allergen-specific immunotherapy (SIT) is the unique modifying treatment of atopic diseases. Dysregulation of T-cell apoptosis plays a crucial role in the in the development of asthma. Nevertheless, the effect of sublingual immunotherapy (SLIT) on T-cell apoptosis has not been elucidated. The aim of the study was to evaluate the influence of 1 year of SIT in atopic children on the frequency of Th1 and Th2 cells in peripheral blood, on T-cell apoptosis, and on the response of basophils to allergen challenge.
Methods: Children suffering from bronchial asthma were treated with SLIT for 12 months (Staloral 300). Basophil activation was evaluated by measurement of CD203c antigen expression. Th1 and Th2 cells frequencies and their associated frequencies of apoptosis by the expression of Bcl-2 were evaluated with flow cytometry.
Results: Basophil activation showed no difference in response before and after therapy. The frequency of Th1 cells increased (p=0.01, n=19), whereas the frequency of Th2 cells remained stable. Additionally, a significant increase of Bcl-2 positive Th1 cells was found (p=0.0465, n=19). Conclusions: We conclude that the increase in frequency of Th1 cells secondary to SLIT might be associated with increased resistance to apoptotic signals. The basophil activation is not useful in evaluation of patient desensitization.

Entities:  

Year:  2014        PMID: 24669352      PMCID: PMC3961768          DOI: 10.1089/ped.2014.0328

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol Pulmonol        ISSN: 2151-321X            Impact factor:   1.349


  37 in total

Review 1.  Biomarkers for allergen immunotherapy in cedar pollinosis.

Authors:  Takao Fujisawa; Mizuho Nagao; Yukiko Hiraguchi; Koa Hosoki; Reiko Tokuda; Satoko Usui; Sawako Masuda; Makito Shinoda; Akihiko Hashiguchi; Masao Yamaguchi
Journal:  Allergol Int       Date:  2009-04-25       Impact factor: 5.836

2.  Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.

Authors:  L Van Overtvelt; V Baron-Bodo; S Horiot; H Moussu; C Ricarte; F Horak; P Zieglmayer; R Zieglmayer; A Montagut; S Galvain; O de Beaumont; M Le Gall; P Moingeon
Journal:  Allergy       Date:  2011-08-29       Impact factor: 13.146

3.  Dendritic cells modification during sublingual immunotherapy in children with allergic symptoms to house dust mites.

Authors:  Federica Angelini; Valentina Pacciani; Stefania Corrente; Romina Silenzi; Alessandra Di Pede; Antonella Polito; Carla Riccardi; Silvia Di Cesare; Marie Laure Yammine; Paolo Rossi; Viviana Moschese; Loredana Chini
Journal:  World J Pediatr       Date:  2010-12-30       Impact factor: 2.764

Review 4.  [The role of interleukin-18 in the pathogenesis of bronchial asthma and other allergic diseases and in activation of basophils and mastocytes].

Authors:  Marek Kamiński; Karolina Kłoda; Andrzej Pawlik
Journal:  Pneumonol Alergol Pol       Date:  2008

Review 5.  Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations.

Authors:  Linda Cox
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

6.  Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.

Authors:  Samuele E Burastero; Gianni Mistrello; Paolo Falagiani; Clara Paolucci; Daniela Breda; Daniela Roncarolo; Stefania Zanotta; Giorgio Monasterolo; Renato E Rossi
Journal:  Ann Allergy Asthma Immunol       Date:  2008-04       Impact factor: 6.347

7.  Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitis.

Authors:  G Ciprandi; M De Amici; M A Tosca; A Pistorio; G L Marseglia
Journal:  Int J Immunopathol Pharmacol       Date:  2009 Oct-Dec       Impact factor: 3.219

8.  Severity of asthma: the role of CD25+, CD30+, NF-kappaB, and apoptotic markers.

Authors:  A S Abdulamir; H S Kadhim; R R Hafidh; M A Ali; I Faik; F Abubakar; K A Abbas
Journal:  J Investig Allergol Clin Immunol       Date:  2009       Impact factor: 4.333

9.  Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.

Authors:  Friedrich Horak; Petra Zieglmayer; René Zieglmayer; Patrick Lemell; Philippe Devillier; Armelle Montagut; Michel Mélac; Sylvie Galvain; Stéphanie Jean-Alphonse; Laurence Van Overtvelt; Philippe Moingeon; Martine Le Gall
Journal:  J Allergy Clin Immunol       Date:  2009-08-03       Impact factor: 10.793

10.  [The usefulness of CD203c expression measurement on basophils after activation with grass pollen and Dermatophagoides pteronyssinus antigens. Preliminary study].

Authors:  Olga Potapińska; Elzbieta Górska; Anna Zawadzka-Krajewska; Marek Kulus; Maria Wasik; Urszula Demkow
Journal:  Pneumonol Alergol Pol       Date:  2009
View more
  2 in total

Review 1.  Effect of allergen-specific immunotherapy on CD4+ T cells.

Authors:  Erik Wambre
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-12

Review 2.  Biomarkers and mechanisms of tolerance induction in food allergic patients drive new therapeutic approaches.

Authors:  Carolyn H Baloh; Michelle F Huffaker; Tanya Laidlaw
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.